Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rikkunshito During Neoadjuvant Chemotherapy for Esophageal Cancer
jRCT1041260034Recruiting
- Start
- Jun 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rikkunshito in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms). Started Jun 2026; status: recruiting.
02
Drugs
rikkunshito
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on jRCT1041260034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260034.